Philip Insel

Philip Insel is an Assistant Professor in the School of Medicine at University of California, San Francisco. His research focuses on the intersection of neurology, psychiatry, and geriatrics, particularly examining biomarkers and neuroimaging in Alzheimer's disease and late-life depression.

• Research Interests: Alzheimer's disease progression, amyloid-beta and tau pathology, neuroimaging, cognitive decline in elderly populations, biomarker validation for neurodegenerative diseases.

Publication Trends (2011–2025): 63% in Neurology, 42% in Psychiatry, 27% in Geriatrics, and 16% in Molecular Biology. Key methodologies include PET imaging, MRI volumetrics, CSF biomarker analysis, and longitudinal clinical trials.

• Collaborative Networks: Alzheimer's Disease Neuroimaging Initiative (ADNI), ADNI Depression Project, A4 Study Team, Swedish BioFINDER study.
• Co-Authors: Paul Aisen, Michael Donohue, Rachel Nosheny, Maria Kryza-Lacombe, Scott Mackin.

Technical Contributions: Development of composite cognitive scores and nonlinear atrophy models for Alzheimer's research. Active in clinical trial design for primary and secondary prevention strategies.